For the field of lung cancers, the high level of LncRNA H19 expression would lead to gefitinib resistance in non-small cell lung cancer, [23] and the presence of LncRNA H19 are associated with the proliferation of lung cancer cells [24]. Here, H19 is linked to non-small cell lung carcinoma.